"k)  regulate  all  matters  pertaining  to  the  conduct  of  clinical"
"trials in Sri Lanka."
"Section  146  of  the  Act  defines  “borderline  products”  as  “the"
"products having combined characteristics of medicines and foods,"
"medicines and medical devices or medicines and cosmetics”."
"Section 14 of the Act, which describes the powers and functions"
"of the National Medicines Regulatory Authority, reads as follows:"
"The powers and functions of the Authority shall be to:"
